La chaîne d'options affiche les données clés des options sur actions de Outlook Therapeutics à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Outlook Therapeutics..

Outlook Therapeutics (NASDAQ:OTLK) Stock, Chaîne d'Options

Outlook Therapeutics

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics Inc

Earnings

News

Banco Macro Q3 Net Income Up 293% YoY, Total Deposits Increase 30% YoY

Florida's Department of Health announced plans to award 22 new medical cannabis licenses, a decision that could reshape the state's cannabis industry but is likely to face legal challenges. 
The announcement, posted Tuesday on the agency's website (<a href="https://www.tallahassee.com/story/news/local/state/2024/11/27/florida-picks-22-applicants-to-get-next-medical-marijuana-licenses/76623095007/">via</a> Tallahassee Democrat), comes more than 18 months after applications closed in April 2023.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42225423/mexico-president-claudia-sheinbaum-to-trump-neither-threats-nor-tariffs-will-solve-your-fentanyl-crisis">Mexico President Claudia Sheinbaum To Trump: &#8216;Neither Threats Nor Tariffs&#8217; Will Solve Your Fentanyl Crisis</a>
The new licenses are a result of a 2017 law mandating an increase in licenses as the number of medical marijuana patients grows, which now surpasses 880,000. This process has attracted significant attention since it marks the first chance for new businesses to enter Florida&#8217;s medical cannabis market since the law&#8217;s enactment.
The department's letters of intent signal approval for 22 businesses out of the 74 that applied last year, each paying a $143,000 application fee. The evaluation process, carried out by consulting firm KPMG, cost the state nearly $1.79 million. However, the letters do not grant immediate operating licenses, leaving room for legal action from applicants who were not selected.
<h3 class="wp-block-heading">Anticipated Legal Battles</h3>
Legal disputes are expected to delay the process, possibly for years, given the competitive nature of <a href="https://www.benzinga.com/24/11/42017405/medical-marijuana-footprint-grows-in-florida-as-legalization-push-fizzles-and-other-new-cannabis-stores-that-launched-sales">Florida's cannabis market. </a>
"Historically, when these sorts of things happen, litigation does occur. You have 22 people that are very happy and 50 people that are not very happy at all," Department of Health spokesperson Jae Williams said in dialogue with The News Service of Florida. 
He also noted the substantial investments made by applicants and the department's responsibility to ensure that approved operators meet high standards for quality.
Applicants have called for legislative intervention to prevent prolonged delays. Attorney Paula Savchenko, who worked with Florida Sports Consultants, Inc.—operating as Belushi's Farm Florida—said the process could stall for months or even years without action.
"If we don't have a legislative fix, we're going to see these licenses held up for anywhere between six months to two years," Savchenko said.
<h3 class="wp-block-heading">Industry Shifts And New Players</h3>
Notable applicants receiving letters include Florida Sports Consultants, Inc., led by actor Jim Belushi, who also operates a cannabis farm in Oregon. Other approved businesses include STIIIZY Florida, LLC, A Good Decision, LLC and Theory Wellness of Florida, LLC. The additions bring Florida closer to doubling its licensed operators, which currently stand at 25, managing over 690 dispensaries statewide.
Quincy-based Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), the state's largest medical marijuana operator, welcomed the expansion. 
"We are pleased that the licenses are finally issued, bringing the number of licensees to 47. We continue to look forward to working with the governor and legislature to expand access to safe, lab-tested cannabis for Floridians," the company said in a statement.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Broader Context</h3>
The decision to award licenses coincides with <a href="https://www.benzinga.com/markets/cannabis/24/11/41780079/floridas-cannabis-initiative-defeated-trulieve-ceo-kim-rivers-nfls-ricky-williams-and-others-res">the defeat of a proposed constitutional amendment </a>that sought to legalize recreational marijuana. 
The measure received 56% voter approval but fell short of the 60% threshold needed for passage. Governor Ron DeSantis played a significant role in opposing the amendment, which had been heavily supported by industry leaders, including Trulieve.
"The majority of people in the industry would rather have had recreational pass, but we all are pretty confident that it's going to pass sometime in the next two to four years," Savchenko said.
For now, Florida's medical marijuana industry is bracing for the next phase, with new players poised to enter the market and potential legal hurdles still ahead.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42222815/cannabis-on-thanksgiving-10-science-backed-benefits-for-a-happier-holiday">Cannabis On Thanksgiving: 10 Science-Backed Benefits For A Happier Holiday</a></li>
</ul>
Cover image made with AI.

Cannabis

Government

Markets

TCNNF

Florida To Award 22 New Cannabis Licenses After 18-Month Wait—Legal Battles Ahead?

The Detroit Lions and Dallas Cowboys traditionally play on Thanksgiving, making NFL games a key part of the holiday, alongside family gatherings and feasts. It is also a day off for the <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/23/11/35930411/is-the-stock-market-closed-on-thanksgiving-traders-prepare-for-a-holiday-break">country's major stock markets</a>.
Along with the Lions and Cowboys, four other NFL teams will be featured across three NFL games on Thanksgiving Day.
Lions and Cowboys Thanksgiving Day Games: Dating back to 1934, the Detroit Lions have played in the annual Thanksgiving Day game. The lone exceptions were the 1939 through 1944 seasons that weren&#8217;t played due to World War II. The games have become a staple for the&nbsp;<a href="https://www.benzinga.com/topic/nfl" target="_blank" rel="noreferrer noopener">National Football League.</a>
The idea for the Thanksgiving Day game was&nbsp;<a href="https://www.espn.com/nfl/story/_/id/32646037/nfl-thanksgiving-day-games-history-lions-cowboys-play-every-year-moments-traditions-records" target="_blank" rel="noreferrer noopener">created&nbsp;</a>by former Lions owner&nbsp;G.A. Richards&nbsp;as a way to increase attendance and media hype for the team. Richards purchased the Portsmouth (Ohio) Spartans and moved them to Detroit before the tradition began.
The first Thanksgiving Day game was watched by more than 26,000 fans.
The Dallas Cowboys played on Thanksgiving Day in 1966, beating the Cleveland Browns 26-14. The Cowboys&#8217; first Thanksgiving Day game was attended by 80,259 people. The Cowboys have played a Thanksgiving Day game every year since except 1975 and 1977.
Similar to the Lions, the Cowboys saw the holiday as a way to create more national media attention for the team.
The Lions created the concept, and the game pre-dates the Super Bowl and many of the NFL teams being created, which makes tradition the biggest reason why the Lions and Cowboys play in their respective games annually.
In 2006, the NFL added a prime-time Thanksgiving Day game that features two rotating teams.
Thanksgiving Day Stats:&nbsp;The Lions lost its first Thanksgiving Day game and haven&#8217;t had success in many of the contests: the franchise holds an all-time 37-45-2 record in Thanksgiving Day games. The Lions have lost seven straight Thanksgiving Day games heading into the 2024 contest.
As the creators of the game concept, the Lions have the most Thanksgiving Day wins with 37, but one of the worst records overall.
The Cowboys have had better success in their games, holding an all-time-record of 33-22-1.
While they don&#8217;t play every year, two other teams largely featured are the&nbsp;Chicago Bears&nbsp;and&nbsp;Green Bay Packers, which hold all-time Thanksgiving Day records of 20-15-2 and 15-20-2, respectively. Both the Bears and Packers play on Thursday.
The&nbsp;Jacksonville Jaguars&nbsp;are the only NFL team to never play in a Thanksgiving Day game. Several teams have never won on Thanksgiving Day, with the Tampa Bay Buccaneers and Cincinnati Bengals each holding a 0-1 record.
Read Also: <a href="https://www.benzinga.com/general/sports-betting/24/08/40555085/sports-illustrated-predicts-detroit-lions-to-win-super-bowl-heres-how-much-100-bet-could-p">Sports Illustrated Predicts Detroit Lions To Win Super Bowl: Here&#8217;s How Much $100 Bet Could Pay If History Is Made</a>
2024 Thanksgiving Day Games:&nbsp;Here&#8217;s a look at the&nbsp;three 2024 Thanksgiving Day games, how to watch and the betting odds.
<ul>
<li>Chicago Bears (4-7) at Detroit Lions (10-1): 12:30 p.m. ET on CBS, a unit of Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>)</li>
<li>New York Giants (2-9) at Dallas Cowboys (4-7): 4:30 p.m. ET on FOX, a unit of Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>)</li>
<li>Miami Dolphins (5-6) at Green Bay Packers (8-3): 8:20 p.m. on NBC, a unit of Comcast Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>)</li>
</ul>
The Giants are 7-6-3 all-time in Thanksgiving Day matches and the Dolphins are 5-2 all-time on Thanksgiving Day.
All three home teams are the favorites in their Thursday games. Betting odds from DraftKings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) show the Lions favored by 9.5 points, the Cowboys favored by 3.5 points and the Packers favored by 3.5 points.
Betting on all three favorites to win pays out with odds of +212, which would turn $100 bet into a profit of $212 if the Lions, Cowboys and Packers all win. Betting on all three favorites to cover the spread and win by the totals listed above would pay out at +638, turning $100 bet into a profit of $638 if all three teams cover.
Betting favorites on Thanksgiving Day are 48-9 straight up and 38-19 against the spread since 2004, according to <a href="https://www.actionnetwork.com/nfl/nfl-thanksgiving-betting-trends-stats-notes-action-network-betting-primer-2024">data </a>from Action Network.
A win by the Bears could be one of the biggest upsets on Thanksgiving Day since 1980 depending on where the spread closes. The current record is the Dolphins beating the Cowboys as 10-point underdogs in 1993. The Packers win over the Lions in 2023 as 8.5-point underdogs ranks second.
Why It's Important: The Thanksgiving Day NFL games could be part of a huge week for sportsbooks. Macquarie analyst Chad Beynon estimates $4.5 billion will be bet by U.S. bettors over Thanksgiving week from Nov. 25 to Dec. 1, as <a href="https://www.casino.org/news/thanksgiving-football-feast-4-5b-in-wagers-expected-this-week/">reported </a>by Casino.org.
This figure would be up 11% year-over-year and comes with a record 38 states and Washington D.C. allowing legal sports betting for this year's Thanksgiving Day games.
Prime-time games, which typically occur at nighttime often see increased betting with more viewers watching. The three Thanksgiving Day games could all be treated like prime-time games according to Beynon.
The Thanksgiving Day games feature the red-hot Lions who have won nine games in a row and are the current betting favorites to win Super Bowl LIX. The Lions are one of <a href="https://www.benzinga.com/general/sports-betting/24/09/40720484/which-4-teams-have-never-reached-the-super-bowl-betting-payouts-if-history-is-made-in-2024">only four teams </a>to never make a Super Bowl appearance.
DraftKings lists the Lions as the Super Bowl favorites at +250, ranking ahead of the Kansas City Chiefs (+450), who are seeking a third-straight championship. The Packers rank sixth with odds of +1,600 and the Dolphins have odds of +9,000.
The other Thursday teams (Giants, Bears, Cowboys) all have odds of +100,000 to win Super Bowl LIX as all will likely miss making the NFL Playoffs.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/sports/24/11/42101566/trump-dance-takes-over-sports-celebrations-move-over-griddy-gronk-spike-athletes-are-paying-tribute-or-poking-fun-at-president-elect">Trump Dance Takes Over Sports Celebrations: Move Over Griddy, Gronk Spike, Athletes Are Paying Tribute (Or Poking Fun) At President-Elect</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
This image used was created using artificial intelligence MidJourney.

Entertainment

Sports Betting

Sports

Media

CMCSA

DKNG

FOXA

PARA

PARAA

Here's Why The Detroit Lions, Dallas Cowboys Always Have Thanksgiving Day NFL Games

FRST

Primis Financial Gets Nasdaq Notice Due To Delayed 10-Q Filing

Quinlan will continue serving on the Board. John Ratigan, Comtech's President and CEO, will report directly to Traub and they will be working closely together.
In addition, former U.S. Army Chief Information Officer, Lieutenant General (Retired) Bruce T. Crawford, has been elected to serve as Lead Independent Director.
&nbsp;

Management

CMTL

Comtech Telecommunications Names Kenneth Traub As Executive Chairman; Mark Quinlan Has Stepped Down As Chairman Of Board

The study found that twice-yearly lenacapavir for pre-exposure prophylaxis (PrEP) was highly efficacious at reducing HIV infections, reducing them by 96% compared to background HIV incidence.&nbsp;
Twice-yearly lenacapavir for PrEP also demonstrated superiority to once-daily Truvada&#xAE; (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg; F/TDF) for PrEP and was generally well-tolerated, with no significant or new safety concerns identified.&nbsp;
&nbsp;

GILD

Gilead Says NEJM Published Full Results From Pivotal Phase 3 Purpose 2 Trial Evaluating Twice-yearly Lenacapavir

AREB

American Rebel Receives Delinquency Notification Letter From Nasdaq

PMEC

Primech Holdings Gets Nasdaq Minimum Bid Price Requirement Extension Until May 12, 2025, To Regain Compliance

CELU

Celularity Receives Notification From Nasdaq About Non-Compliance With Continued Listing Requirements

Retailers are expecting a record-breaking Black Friday to Cyber Monday shopping period as cash-strapped consumers are expected to shop early in the holiday season for sales <a href="https://www.benzinga.com/news/retail-sales/24/11/42220200/black-friday-discounts-too-good-to-be-true-survey-shows-only-42-of-sales-are-authentic">promotions and savings.&nbsp;</a>
What To Know: Management consultancy firm Bain &amp; Company <a href="https://www.bain.com/insights/black-friday-2024-sales-forecast-snap-chart/">forecasts</a> U.S. retail sales during the Black Friday to Cyber Monday period will reach $75 billion for the first time ever, growing by about 5% year-over-year. The firm sees about 8% of total holiday sales will come during this period, the highest share since 2019, underscoring the importance of the key shopping period for retailers.&nbsp;
"The holiday shopping season has been reshaped in recent years, where consumers are making purchases earlier, driven by a stream of discounts that has allowed shoppers to manage their budgets in different ways," says Vivek Pandya, lead analyst, Adobe Digital Insights.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/retail-sales/24/11/42170721/thanksgiving-dinner-gobbles-up-19-more-cash-this-year-many-holiday-hosts-already-regret-their-decision">Thanksgiving Dinner Gobbles Up 19% More Cash This Year, Many Holiday Hosts &#8216;Already Regret Their Decision&#8217;</a>
Online Shopping: Adobe Digital Insights <a href="https://news.adobe.com/news/2024/09/092524-adi-holiday-forecast">expects</a> Cyber Week (the 5-day period including Thanksgiving, Black Friday and Cyber Monday) online sales of $40.6 billion, up 7% over last year and adding up to 16.9% of the overall holiday season sales.&nbsp;
Adobe sees Cyber Monday as the biggest shopping day of the year, driving a record $13.2 billion in sales, an increase of 6.1% from 2023.&nbsp;
In-store Shopping: In-store shopping still remains an important part of Black Friday for many consumers. According to<a href="https://www.linkedin.com/redir/redirect?url=http%3A%2F%2FPlacer%2Eai&amp;urlhash=w5Z_&amp;trk=article-ssr-frontend-pulse_little-text-block"> Placer.ai</a> analytics, Black Friday 2023 saw a 300% increase in mall visits compared to the first three weeks of November. Superstores also saw an 81% rise, demonstrating demand across shopping formats.&nbsp;
Most Wanted Items: Consumers are expected to gobble up Cyber Week deals on electronics from retailers like Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) on hot items like Beats Studio Pro Wireless Noise Cancelling Headphones at more than 60% off its regular price.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/retail-sales/24/11/42220200/black-friday-discounts-too-good-to-be-true-survey-shows-only-42-of-sales-are-authentic">Black Friday Discounts Too Good To Be True? Survey Shows Only 42% Of Sales Are Authentic</a>
Placer.ai expects beauty and personal care items to be another hot item with discounts on gift sets from retailers like Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) drawing shoppers online and in stores.&nbsp;
Sporting goods and outdoor equipment will see record-high discounts averaging 20%, according to Abode Digital Insights, with retailers like Dicks Sporting Goods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) benefiting from the increased spending on experiences and activities.&nbsp;
When To Shop: Adobe Digital Insights says Thanksgiving Day will be the best day to shop for toys, appliances, furniture and sporting goods, while Black Friday will offer the deepest discounts for TVs. The Saturday after Thanksgiving will have the best deals for computers and Cyber Monday will be the best day to shop for electronics and apparel, the two biggest categories in e-commerce by revenue share. 
Read More: • <a href="https://www.benzinga.com/24/11/42194570/starbucks-employee-systems-down-after-software-provider-suffers-ransomware-attack">Starbucks&#8217; Employee Systems Down After Software Provider Suffers Ransomware Attack</a>
Photo: gonghuimin468 from Pixabay

Retail Sales

General

ULTA

Black Friday, Cyber Monday Shopping Set To Break Sales Records

XELB

XCEL BRANDS Receives Delinquency Notification Letter From Nasdaq

Shares of Autodesk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) are trading lower on Wednesday but they may have found support. The company posted earnings that were <a href="https://www.benzinga.com/news/offerings/24/11/42202548/autodesk-stock-slides-on-q3-earnings-key-details-from-quarter">slightly better than estimates</a> but investors are concerned about decreasing margins.
Our team of traders and technical analysts has made it our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
Operating margin is the percent of profit a company has on a dollar of sales after all costs are considered. In Q3 of last year, Autodesk had an operating margin of 24%. This means that for every dollar of sales, the company kept 24 cents.
But this year, the margin has dropped to 22%. This means they are now only keeping 22 cents. This may not sound like a significant drop, but it shows that the company is becoming less efficient. This may be a bearish sign for the longer-term and some investors are selling.
It isn't a coincidence that the shares found support around the $293 level.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="532" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-1024x532.png" alt="Autodesk" class="wp-image-668317" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-1024x532.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-768x399.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2-1536x798.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/27164814/11-2.png 1567w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42216384/feds-favorite-inflation-gauge-heats-up-as-predicted-personal-incomes-soar-december-interest-rate-cut-in-doubt">Fed&#8217;s Favorite Inflation Gauge Heats Up As Predicted, Personal Incomes Soar</a>
As you can see on the chart, this level was resistance in October. Many of the investors and traders who sold at this resistance thought they made a good decision when the price dropped soon after.
But in early November the resistance broke and the stock gapped higher. When this happened, some of those who sold came to regret their decision to do so. A number of them decided to buy their shares back.
But they would only do so if they could buy them at the same price they were sold for.
As a result, now that the stock has dropped back to their selling prices they are placing buy orders. The large concentration of these orders has formed support at the price that had been resistance.
Sometimes stocks rally after they drop to resistance.
This happens because some of the buyers become nervous. They know that the sellers are going to go to whoever is willing to pay the highest price. They are afraid that they will be outbid by other buyers.
So, they increase their bid prices. Other nervous buyers see this and do the same thing. It could result in a snowball effect or bidding war that pushes the price up.
Levels that had been resistance can become support. Stocks tend to rally after reaching support. Shares of Autodesk may be about to move higher.
Price Action: Autodesk closed Wednesday at $290.64 per share, down 8.6%. 
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42197276/anthony-scaramucci-trump-win-is-the-greatest-political-comeback-in-us-history-crypto-surge-following-it-was-3-years-overdue">Anthony Scaramucci: Trump Win Is &#8216;The Greatest Political Comeback In US History,&#8217; Crypto Surge Following It Was 3 Years Overdue</a>

Technicals

Trading Ideas

ADSK

Stock Of The Day: Autodesk Beats Earnings As Shares Find Support At This Level

Canada has started preparing for potential retaliatory tariffs on U.S. goods following President-elect Donald Trump's recent threats to impose sweeping <a href="https://www.benzinga.com/topic/canada">duties on Canadian imports.</a> 
A senior Canadian government official told <a href="https://apnews.com/article/canada-trump-tariffs-trudeau-c741393c2f7c7545e9714839cfbbda45">AP News</a> Wednesday that discussions are underway to target certain U.S. items if Trump follows through on his proposed 25% tariff, although no final decision has been made.
This move comes as Trump renews his hardline stance on trade, calling for punitive tariffs to address what he described as the flow of drugs and migrants across both the northern and southern borders. 
Canada has faced a similar situation in the past, such as in 2018 when it imposed billions of dollars in retaliatory duties on U.S. goods after the Trump administration hiked tariffs on Canadian steel and aluminum.
<h3 class="wp-block-heading">Canadian Dollar Poised For Further Declines</h3>
Wall Street analysts expect additional downside in the Canadian dollar – as tracked by the Invesco CurrencyShares Canadian Dollar Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXC#NYSE">FXC</a>) – if the tariff threats materialize.
Robert Kavcic, senior economist at BMO Economics, highlighted Canada's vulnerability as a &#8220;small, open economy&#8221; heavily reliant on U.S. trade. 
&#8220;The U.S. market accounts for roughly 75% of Canadian goods exports, which in total comprise about 25% of Canadian GDP,&#8221; Kavcic wrote in a note.
"In general, we'd expect the Canadian dollar to see the biggest and most immediate market impact, extending the weakness seen in recent months. In this event, we see room for further depreciation from recent levels above 1.41 against the dollar."
Shaun Osborne, chief forex strategist at Scotiabank, also expressed skepticism about Canada's ability to quickly address the incoming administration&#8217;s concerns. 
Osborne explained that Trump's newly appointed &#8220;border czar,&#8221; Tom Homan, has already labeled the northern border as &#8220;an extreme national security issue,&#8221; which could complicate negotiations.
&#8220;More CAD losses seem inevitable unless the Canadian government can muster a response that satisfies the incoming administration quickly, however. That may not be easy,&#8221; Osborne warned. 
He continued, &#8220;The risk of 25% tariffs remains just that at the moment, but the longer the threat lingers and the closer we get to the inauguration, the weaker the CAD may trade."
According to data from the U.S. Census Bureau, U.S. imports from Canada reached $481 billion in 2023, while Canadian imports of U.S. goods amounted to $354 billion during the same period.
In terms of products, Canada's top export to the United States was crude oil and other fuels, totaling approximately $120 billion, followed by vehicles at $58 billion.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42219612/usmexico-trade-tensions-escalate-as-mexican-peso-hits-august-2022-lows-why-is-auto-industry-most-at-risk">US–Mexico Trade Tensions Escalate As Mexican Peso Hits August 2022 Lows: Why Is Auto Industry Most At Risk?</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Macro Economic Events

Regulations

Currency ETFs

Politics

Forex

Global

Economics

Analyst Ratings

ETFs

Canada Prepares Retaliatory Tariffs After Trump Threats: Analysts Warn Of Further Loonie Weakness

Mexican President Claudia Sheinbaum responded to U.S. President-elect Donald Trump in a letter published Tuesday, addressing the issue of the <a href="https://www.benzinga.com/markets/cannabis/24/03/37445551/overdose-crisis-worsens-the-rise-of-fentanyl-smoking-leads-to-even-more-deaths-than-shooting-her">fentanyl crisis</a> and broader drug-related challenges.
Her message emphasized cooperation over confrontation — whereas Trump has a <a href="https://www.benzinga.com/news/24/10/41563454/trumps-escalating-threats-to-rivals-100-and-counting">penchant for the latter</a>.
&#8220;Neither threats nor tariffs will solve the migration or the drug abuse phenomenon in the US,&#8221; Sheinbaum <a href="https://x.com/Claudiashein/status/1861558804652999130">said</a>, calling for collaborative solutions to mitigate the escalating drug crisis.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Migración y consumo de fentanilo no se atenderán con amenazas ni aranceles. México avanza con resultados en acciones integrales; la cooperación y el entendimiento son necesarios. El diálogo es el camino. <a href="https://t.co/mwXkhUCwbL">pic.twitter.com/mwXkhUCwbL</a>
&mdash; Claudia Sheinbaum Pardo (@Claudiashein) <a href="https://twitter.com/Claudiashein/status/1861558804652999130?ref_src=twsrc%5Etfw">November 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h3 class="wp-block-heading">Sheinbaum To Trump: Fentanyl &#8216;Is An Issue In Your Country&#8217; </h3>
&#8220;For humanitarian reasons, we have consistently expressed Mexico&#8217;s commitment to preventing the continuation of the <a href="https://www.benzinga.com/general/health-care/24/11/42146502/us-overdose-deaths-decline-as-fentanyl-potency-weakens-harm-reduction-expands">fentanyl epidemic</a> in the United States, which, moreover, is an issue of consumption and public health in your country,&#8221; Sheinbaum says in the letter, which she read during her usual morning conferences. 
Sheinbaum detailed Mexico's recent measures, including enforcement actions by the armed forces and prosecutors. According to the data she shared, in 2024 alone, authorities seized large quantities of &#8220;various drugs&#8221;, confiscated over 10,340 firearms, and arrested more than 15,640 individuals for drug-related violence.
Furthermore, she noted Mexico&#8217;s legislative progress toward stricter penalties.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Not Us</h3>
Sheinbaum called attention to the illicit flow of chemical precursors from Asia, which enter North America through Canada, the U.S., and Mexico. 
She stressed that addressing this issue requires international collaboration: &#8220;It is publicly known that these precursors are smuggled into North America. This makes global cooperation imperative.&#8221;
The president juxtaposed the flow of drugs with the southbound<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42166673/drug-cartels-use-tether-and-bitcoin-to-launder-millions-court-documents-reveal"> illegal trafficking</a> of <a href="https://www.benzinga.com/topic/guns">firearms</a> from the U.S. into Mexico. 
She cited stark statistics: 70% of illegal weapons seized in Mexico originate in the U.S., fueling violence. 
&#8220;The synthetic drugs are not consumed by us, and the weapons are not produced here. Yet, we bear the brunt of the deaths caused by organized crime in response to the demand for drugs in your country.&#8221;
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42069004/how-trumps-election-could-revolutionize-cannabis-and-cryptocurrency-ceo-says">How Trump&#8217;s Election Could Revolutionize Cannabis And Cryptocurrency, CEO Says</a>
<h3 class="wp-block-heading">&#8216;Reciprocal Understanding And Cooperation&#8217;</h3>
Sheinbaum rejected the efficacy of punitive tariffs in addressing these challenges. 
Instead, she urged for &#8220;reciprocal understanding and cooperation&#8221; between the two nations. 
She noted that mutual economic ties, especially in industries like automotive manufacturing, <a href="https://www.benzinga.com/news/global/24/11/42198583/will-trump-lead-us-into-trade-war-with-mexico-president-claudia-sheinbaum-rebukes-threats">would suffer</a> under an antagonistic approach, leading to inflation and job losses on both sides of the border, and posed that both Mexico and the U.S. should work together on a mobility program instead of reinforcing the borders. 
&#8220;I am convinced that North America's economic strength lies in preserving our commercial partnership. Dialogue is the best path toward understanding, peace, and prosperity for our nations,&#8221; she added.
<ul>
<li>Read Next:<a href="https://www.benzinga.com/economics/macro-economic-events/24/11/42202496/goldman-sachs-expects-major-selloffs-in-canadian-dollar-mexican-peso-says-trump-tariffs-threaten-usmca-agreement"> Goldman Sachs Expects Major Selloffs In Canadian Dollar, Mexican Peso, Says Trump Tariffs Threaten USMCA Agreement</a></li>
</ul>
Translations in this article were made by Rolando García
Cover: Shutterstock.

Mexico President Claudia Sheinbaum To Trump: 'Neither Threats Nor Tariffs' Will Solve Your Fentanyl Crisis

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares have been treading water for the better part of the past month. The company reported earnings at the end of October. Here&#8217;s a look at what <a href="https://www.benzinga.com/general/social-media/24/11/42177636/meta-heads-to-trial-over-instagram-whatsapp-acquisitions">you need to know</a>.
What To Know: Meta shares have struggled to move higher since the company reported third-quarter financial results last month. Although Meta <a href="https://www.benzinga.com/news/earnings/24/10/41637326/meta-platforms-q3-earnings-revenue-beat-eps-beat-daily-actives-up-5-strong-momentum-in-ai">beat analyst estimates</a> on the top and bottom lines as revenue jumped 19% and daily actives climbed 5%, the stock faced selling pressure due to spending concerns. 
Meta raised its full-year 2024 capital expenditures&nbsp;outlook by $1 billion and said it continues to expect operating losses to &#8220;increase meaningfully&#8221; year-over-year&nbsp;for Reality Labs.
It&#8217;s worth noting that insiders have been selling Meta shares in recent months. CEO Mark Zuckerberg, CFO Susan Li and COO Javier Olivan all sold shares in November under trading plans, with Olivan most recently selling shares on Monday, according to Benzinga <a href="https://www.benzinga.com/quote/META/insider-trades">data</a>.
On a positive note, <a href="https://www.axios.com/2024/11/26/exclusive-threads-adds-35m-new-signups-this-month">Axios</a> reported Wednesday that Meta&#8217;s Threads has added 35 million new users on the platform since Nov. 1. Micro-blogging startup Bluesky has seen users flock to the platform since Election Day, suggesting users are leaving X because of Elon Musk&#8217;s political views. Meta also appears to be a beneficiary.
Check This Out: <a href="https://www.benzinga.com/24/11/42193222/orange-taps-openai-meta-to-create-ai-that-speaks-african-languages">Meta, OpenAI, Orange Join Forces To Build AI Models For African Languages</a>
On the earnings call last month, Zuckerberg said Threads had over 275 million monthly active users. That number appears to be growing rapidly with Axios reporting that the app has seen more than one million daily sign-ups for three months straight.
Meta aims to capitalize on the momentum. Zuckerberg on Monday said Threads is testing a new feature that will allow users to choose what they see when they open the app. Previously, Threads directed users to a default feed, but users can now choose to only see posts from accounts they follow.
Meta is also set to <a href="https://www.benzinga.com/general/social-media/24/11/42177636/meta-heads-to-trial-over-instagram-whatsapp-acquisitions">head to trial in April</a> after Judge James Boasberg rejected Meta&#8217;s attempted dismissal of the case and set a court date earlier this week. The Facebook parent company will face U.S. Federal Trade Commission allegations that it acquired Instagram and WhatsApp&nbsp;to stifle competition in the social media space. 
META Price Action: Meta shares closed Wednesday down 0.76% at $569.20, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

Movers

What's Up With Meta Stock Lately?

The cryptocurrency <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">XRP Token</a> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) from Ripple has soared in price over the last week, with optimism coming from an XRP exchange-traded fund and news that Ripple will invest in a newly rebranded <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42220218/ripple-to-invest-in-rebranded-xrp-exchange-traded-product-by-bitwise">Physical XRP ETP.</a>
While Ripple has hit new 52-week highs, the cryptocurrency remains down from all-time highs.
What Happened: Asset manager WisdomTree recently filed to establish a trust that could lead to the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42170669/wisdomtree-files-for-xrp-etf-trust-report">launch of an XRP ETF.</a>
This move follows others like Bitwise who have already filed to launch similar ETFs. On Wednesday, Ripple announced it would invest in the new rebranded Bitwise Physical XRP ETP.
&#8220;Global demand for exposure to the crypto asset class has exploded in 2024,&#8221; Ripple CEO Brad Garlinghouse said in a&nbsp;<a href="https://www.globenewswire.com/news-release/2024/11/27/2987978/0/en/Bitwise-Rebrands-XRP-ETP-Ripple-To-Invest-in-Product.html" target="_blank" rel="noreferrer noopener">statement</a>. &#8220;XRP is at the forefront of this momentum, standing out as a cornerstone for those seeking access to assets that are resilient and have real-world utility.&#8221;
Bitwise CEO Hunter Horsley said XRP's utility and reliability are among the reasons investors are excited about XRP.
&#8220;XRP and the XRP Ledger are among the most familiar and trusted blockchains in crypto," Horsley said.
With Bitcoin and Ethereum ETFs already approved, cryptocurrency experts see ETFs based on other top 10 cryptos by market capitalization like Solana, Dogecoin and XRP as the&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011875/solana-ripple-litecoin-etfs-may-be-on-the-table-under-trump-administration-industry-experts-think" target="_blank" rel="noreferrer noopener">next to be approved.</a>
The XRP token has gone through many wild swings over the years, with a case brought on by the SEC alleging XRP to be a security, sending the price and interest in the cryptocurrency down. A landmark court ruling that said XRP was not a security helped bring the cryptocurrency&#8217;s price back up.
While XRP has risen in value in recent months, the cryptocurrency remains down from all-time highs.
Read Also: <a href="https://www.benzinga.com/general/education/24/11/42173824/if-you-invested-1000-in-xrp-token-when-sec-lawsuit-caused-mass-panic-heres-how-much-youd-have-today">If You Invested $1,000 In XRP Token When SEC Lawsuit Caused Mass Panic, Here&#8217;s How Much You&#8217;d Have Today</a>
Investing $100 in XRP Today: XRP trades at $1.51 at the time of writing, up 9% over the last 24 hours.
A $100 investment today could purchase 66.2252 XRP.
XRP hit an all-time high of $3.84 on June 4, 2018.
If XRP returns to its 2018 all-time high of $3.84, the $100 investment would be worth $254.30. This represents a potential gain of 154.3%.
There is no guarantee that the XRP Token will return to its all-time highs.
The hypothetical investment shows that a small investment could gain over time if the cryptocurrency market returns to its high mark.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41908812/if-you-invested-100-in-dogecoin-when-the-meme-coin-launched-heres-how-much-youd-have-today">If You Invested $100 In Dogecoin When The Meme Coin Launched, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$XRP

Here's How Much $100 Invested In XRP Token Today Will Be Worth If Crypto Returns To All-Time Highs

Offerings

Cyngn Files For Offering Of Up To 3.06M Units, Up To 3.06M Pre-Funded Units

APLT

Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption Times

CTHR

Charles & Colvard Receives Nasdaq Notice About Non-Compliance Of Listing Rule 5250(c)(1)

Velocity Financial Files For Stock Shelf Of Up To $100M

Outlook Therapeutics, Inc. (OTLK) Q3 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Outlook Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/otlk-stock-quote/">OTLK</a>) just reported results for the third quarter of 2024.<ul><li>Outlook Therapeutics reported earnings per share of -83 cents. This was above the analyst estimate for EPS of -$1.01.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/otlk-stock-earnings-outlook-therapeutics-for-q3-of-2024/">OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024

Analyst Tim Chiang from Capital One Financial assigned a Buy rating on Outlook Therapeutics (OTLK – Research Report) and keeping the price target a...

Outlook Therapeutics Poised for Growth: Strong Buy Recommendation Amidst Positive Clinical and Financial Developments

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Outlook Therapeutics (OTLK – Research Report), Arr...

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), Arrowhead Pharmaceuticals (ARWR) and Syndax Pharmaceuticals (SNDX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Outlook Therapeutics (OTLK – Research Report), 60 ...

Analysts Offer Insights on Healthcare Companies: Outlook Therapeutics (OTLK), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Gritstone Oncology (GRTS)

Outlook Therapeutics: Poised To Jump With Wet AMD Treatment If It Can Overcome FDA Hurdles

In a report released today, Tim Chiang from Capital One Financial assigned a Buy rating on Outlook Therapeutics (OTLK – Research Report), with a pr...

Buy Rating Affirmed for Outlook Therapeutics Amid Strong Market Potential and Upcoming Milestones for ONS-5010/Lytenava

BTIG analyst Julian Harrison reiterated a Buy rating on Outlook Therapeutics (OTLK – Research Report) today and set a price target of $50.00. Julia...

Outlook Therapeutics: Poised to Capitalize on Market Opportunities with LYTENAVA Amidst Industry Shifts

Outlook Therapeutics (OTLK) announced preliminary topline results of Norse Eight, the second of two adequate and well controlled clinical trials ev...

Outlook Therapeutics reports preliminary results from Norse Eight trials

Outlook plunges as lead asset fails in wet AMD study

ARWR

GRTS

OTLK

SNDX

SXTP

Press Releases

Outlook Therapeutics® to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update

Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial

Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series

Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series

Legal

OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment

Health Care

Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference

Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Anixa Biosciences

Avalo Therapeutics

Cabaletta Bio

Cibus

Coya Therapeutics

Cardiff Oncology

Immunic

INmune Bio

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Invizyne Technologies Inc. - Common Stock

Invizyne Technologies

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Leap Therapeutics

MediciNova

Monopar Therapeutics

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

Pyxis Oncology

Regulus Therapeutics

Repare Therapeutics

Skye Bioscience

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

BTIG

Ascendiant Capital

Chardan Capital

HC Wainwright & Co.

Guggenheim

WIIM

Outlook Therapeutics shares are trading lower after the company announced it plans to resubmit the biologics license application for ONS-5010 after reporting preliminary topline results of its Norse eight clinical trial.

Comments

Outlook Therapeutics

Outlook Therapeutics (OTLK) Options

Outlook Therapeutics (NASDAQ:OTLK) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL